Sign in to continue:

Friday, March 6th, 2026

United Company RUSAL Announces Board Meeting to Approve 2025 Annual Financial Results on March 17, 2026 1

United Company RUSAL Announces Upcoming Board Meeting to Approve Annual Financial Results

Key Announcement:
United Company RUSAL, international public joint-stock company, has formally notified investors that its Board of Directors will convene a meeting on Tuesday, 17 March 2026. The main agenda for this meeting will be the approval and announcement of the Company’s annual financial results for the fiscal year ended 31 December 2025.

Key Points for Investors

  • Scheduled Board Meeting: The board meeting is set for 17 March 2026. At this meeting, the annual financial results for 2025 will be reviewed and approved. This is a significant event for investors, as the financial results announcement often has a direct impact on share prices, reflecting the company’s performance for the year.
  • Potential Price Sensitivity: The disclosure of annual financial results is a material event. Depending on the performance of United Company RUSAL in 2025, this announcement could lead to movements in the company’s share price on the Hong Kong Stock Exchange (HKSE), Moscow Exchange, and SPB Exchange. Investors should be prepared for potential volatility surrounding the announcement date.
  • Board Composition: The announcement provides a detailed list of the current Board of Directors, which includes several executive, non-executive, and independent non-executive directors. This information is important for shareholders who monitor corporate governance and leadership stability:

    • Executive Directors: Mr. Evgenii Nikitin (General Director, Executive Director), Ms. Natalia Albrekht, Ms. Elena Ivanova
    • Non-Executive Directors: Mr. Semen Mironov, Mr. Anton Egorov, Ms. Anna Malevinskaya
    • Independent Non-Executive Directors: Mr. Christopher Burnham, Ms. Liudmila Galenskaia, Mr. Kevin Parker, Dr. Evgeny Shvarts, Ms. Anna Vasilenko, Mr. Bernard Zonneveld (Chairman), Mr. Timothy Talkington, Mr. Vladimir Cherniavskii
  • Availability of Announcements: All official company announcements, including the upcoming financial results, will be accessible to investors via the company’s official website:
    English version and
    Russian version.

Why This Matters to Shareholders

The annual financial results represent a comprehensive summary of RUSAL’s performance throughout 2025. These figures will influence analyst projections, dividend expectations, and investor sentiment. Any unexpected performance—whether positive or negative—can trigger significant share price movements. Shareholders should monitor this date closely for updates that may impact their investment decisions.

Additional Notes

  • Corporate Structure: United Company RUSAL is incorporated under the laws of Jersey and continued in the Russian Federation as an international company, reflecting its multinational status and reach.
  • Stock Codes: The company’s securities are listed under HKSE Stock Code: 486, Moscow Exchange Security Code: RUAL, and SPB Exchange Security Code: RUAL.

Disclaimer: This article is intended for informational purposes only and does not constitute investment advice. Investors should consult their financial advisors and refer to official company disclosures before making any investment decisions. The upcoming financial results announcement may contain material information impacting share prices, but the actual outcome cannot be predicted in advance.

View RUSAL Historical chart here



Lee & Man Paper Manufacturing Limited Announces Board Meeting to Approve 2025 Final Results and Dividend on March 10, 2026 1

Lee & Man Paper Manufacturing Limited Announces Upcoming Board Meeting to Approve Final Results and Dividend Lee & Man Paper Manufacturing Limited Schedules Board Meeting for Final Results and Dividend Consideration Key Highlights for...

HBM Holdings Enters $1.1 Billion License and Equity Partnership with Solstice Oncology for HBM4003 Global Development 12

HBM Holdings Announces Major Licensing and Equity Partnership with Solstice Oncology for HBM4003 HBM Holdings Limited (Stock Code: 02142) has made a significant announcement that is likely to draw the attention of shareholders and...

Hope Life International Holdings Limited Announces Board Meeting for 2025 Annual Results and Dividend Consideration

Hope Life International Holdings Limited Announces Board Meeting to Approve 2025 Annual Results Hope Life International Holdings Limited Schedules Board Meeting to Approve 2025 Annual Results Hope Life International Holdings Limited (Stock Code: 1683),...

   Ad